-
1
-
-
0030857028
-
Testicular germ-cell cancer
-
Bosl GJ and Motzer RJ: Testicular germ-cell cancer. N Engl J Med 337: 242-253, 1997.
-
(1997)
N Engl J Med
, vol.337
, pp. 242-253
-
-
Bosl, G.J.1
Motzer, R.J.2
-
2
-
-
0037316970
-
Molecular determinants of treatment response in human germ cell tumors
-
Mayer F, Stoop H, Scheffer GL, Scheper R, Oosterhuis JW, Looijenga LH and Bokemeyer C: Molecular determinants of treatment response in human germ cell tumors. Clin Cancer Res 9: 767-773, 2003.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 767-773
-
-
Mayer, F.1
Stoop, H.2
Scheffer, G.L.3
Scheper, R.4
Oosterhuis, J.W.5
Looijenga, L.H.6
Bokemeyer, C.7
-
3
-
-
23944440892
-
Recent advances in conventional-dose salvage chemotherapy in patients with cisplatin-resistant or refractory testicular germ cell tumors
-
Farmakis D, Pectasides M and Pectasides D: Recent advances in conventional-dose salvage chemotherapy in patients with cisplatin-resistant or refractory testicular germ cell tumors. Eur Urol 48: 400-407, 2005.
-
(2005)
Eur Urol
, vol.48
, pp. 400-407
-
-
Farmakis, D.1
Pectasides, M.2
Pectasides, D.3
-
4
-
-
0031037241
-
A prognostic factor-based staging system for metastatic germ cell cancers
-
International Germ Cell Consensus Classification IGCCC
-
International Germ Cell Consensus Classification (IGCCC): A prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15: 594-603, 1997.
-
(1997)
J Clin Oncol
, vol.15
, pp. 594-603
-
-
-
5
-
-
34548093252
-
The management of stage I nonseminomatous testicular germ cell tumors
-
Pectasides D, Farmakis D and Pectasides M: The management of stage I nonseminomatous testicular germ cell tumors. Oncology 71: 151-158, 2006.
-
(2006)
Oncology
, vol.71
, pp. 151-158
-
-
Pectasides, D.1
Farmakis, D.2
Pectasides, M.3
-
6
-
-
0031466945
-
Lack of correlation between cisplatin-induced apoptosis, p53 status and expression of Bcl-2 family proteins in testicular germ cell tumour cell lines
-
Burger H, Nooter K, Boersma AW, Kortland CJ and Stoter G: Lack of correlation between cisplatin-induced apoptosis, p53 status and expression of Bcl-2 family proteins in testicular germ cell tumour cell lines. Int J Cancer 73: 592-599, 1997.
-
(1997)
Int J Cancer
, vol.73
, pp. 592-599
-
-
Burger, H.1
Nooter, K.2
Boersma, A.W.3
Kortland, C.J.4
Stoter, G.5
-
7
-
-
0030977823
-
MIB-1 immunohistochemistry in clinical stage I nonseminomatous testicular germ cell tumors predicts patients at low risk for metastasis
-
Albers P, Bierhoff E, Neu D, Fimmers R, Wernert N and Müller SC: MIB-1 immunohistochemistry in clinical stage I nonseminomatous testicular germ cell tumors predicts patients at low risk for metastasis. Cancer 79: 1710-1716, 1997.
-
(1997)
Cancer
, vol.79
, pp. 1710-1716
-
-
Albers, P.1
Bierhoff, E.2
Neu, D.3
Fimmers, R.4
Wernert, N.5
Müller, S.C.6
-
8
-
-
0032169646
-
Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis
-
Heidenreich A, Sesterhenn IA, Mostofi FK and Moul JW: Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis. Cancer 83: 1002-1011, 1998.
-
(1998)
Cancer
, vol.83
, pp. 1002-1011
-
-
Heidenreich, A.1
Sesterhenn, I.A.2
Mostofi, F.K.3
Moul, J.W.4
-
9
-
-
34249303467
-
Kit expression in male germ cell tumors
-
Nikolaou M, Valavanis C, Aravantinos G, Fountzilas G, Tamvakis N, Lekka I, Arapantoni-Dadioti P, Zizi A, Ghiconti I, Economopoulos T and Pectasides D: Kit expression in male germ cell tumors. Anticancer Res 27: 1685-1688, 2007.
-
(2007)
Anticancer Res
, vol.27
, pp. 1685-1688
-
-
Nikolaou, M.1
Valavanis, C.2
Aravantinos, G.3
Fountzilas, G.4
Tamvakis, N.5
Lekka, I.6
Arapantoni-Dadioti, P.7
Zizi, A.8
Ghiconti, I.9
Economopoulos, T.10
Pectasides, D.11
-
10
-
-
0035009052
-
Correlation between Topo II alpha expression and chemosensitivity testing for Topo II-targeting drugs in gynaecological carcinomas
-
Koshiyama M, Fujii H, Kinezaki M and Yoshida M: Correlation between Topo II alpha expression and chemosensitivity testing for Topo II-targeting drugs in gynaecological carcinomas. Anticancer Res 21: 905-910, 2001.
-
(2001)
Anticancer Res
, vol.21
, pp. 905-910
-
-
Koshiyama, M.1
Fujii, H.2
Kinezaki, M.3
Yoshida, M.4
-
11
-
-
34247618746
-
Topoisomerase II alpha expression in testicular germ cell tumors
-
Dimov ND, Zynger DL, Luan C, Kozlowski JM and Yang XJ: Topoisomerase II alpha expression in testicular germ cell tumors. Urology 69: 955-961, 2007.
-
(2007)
Urology
, vol.69
, pp. 955-961
-
-
Dimov, N.D.1
Zynger, D.L.2
Luan, C.3
Kozlowski, J.M.4
Yang, X.J.5
-
12
-
-
61449129788
-
Cyclooxygenase-1 and -2 in human testicular tumours
-
Hase T, Yoshimura R, Matsuyama M, Kawahito Y, Wada S, Tsuchida K, Sano H and Nakatani T: Cyclooxygenase-1 and -2 in human testicular tumours. Cancer 95: 301-308, 2002.
-
(2002)
Cancer
, vol.95
, pp. 301-308
-
-
Hase, T.1
Yoshimura, R.2
Matsuyama, M.3
Kawahito, Y.4
Wada, S.5
Tsuchida, K.6
Sano, H.7
Nakatani, T.8
-
13
-
-
0003486931
-
-
World Health Organization:, WHO Offset Publication No 48, Geneva, Switzerland: World Health Organization
-
World Health Organization: WHO Handbook for Reporting Results of Cancer Treatment (WHO Offset Publication No 48). Geneva, Switzerland: World Health Organization, 1979.
-
(1979)
WHO Handbook for Reporting Results of Cancer Treatment
-
-
-
14
-
-
0344872710
-
Two cycles of carboplatin-based adjuvant chemotherapy for high-risk clinical stage I and stage IM non-seminomatous germ cell tumours of the testis: A HECOG trial
-
Pectasides D, Skarlos D, Dimopoulos AM, Farmakis D, Pectasides M, Fountzilas G and Aravantinos G: Two cycles of carboplatin-based adjuvant chemotherapy for high-risk clinical stage I and stage IM non-seminomatous germ cell tumours of the testis: a HECOG trial. Anticancer Res 23: 4239-4244, 2003.
-
(2003)
Anticancer Res
, vol.23
, pp. 4239-4244
-
-
Pectasides, D.1
Skarlos, D.2
Dimopoulos, A.M.3
Farmakis, D.4
Pectasides, M.5
Fountzilas, G.6
Aravantinos, G.7
-
15
-
-
0033038242
-
Platinum-based chemotherapy of primary extragonadal germ cell tumours: The Hellenic Cooperative Oncology Group experience
-
Pectasides D, Aravantinos G, Visvikis A, Bakoyiannis C, Halikia A, Kalofonos C, Kosmidis P, Skarlos D and Fountzilas G: Platinum-based chemotherapy of primary extragonadal germ cell tumours: the Hellenic Cooperative Oncology Group experience. Oncology 57: 1-9, 1999.
-
(1999)
Oncology
, vol.57
, pp. 1-9
-
-
Pectasides, D.1
Aravantinos, G.2
Visvikis, A.3
Bakoyiannis, C.4
Halikia, A.5
Kalofonos, C.6
Kosmidis, P.7
Skarlos, D.8
Fountzilas, G.9
-
16
-
-
11144355665
-
Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: A phase II study
-
Pectasides D, Pectasides M, Farmakis D, Aravantinos G, Nikolaou M, Koumpou M, Gaglia A, Kostopoulou V, Mylonakis N and Skarlos D: Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II study. Ann Oncol 15: 493-497, 2004.
-
(2004)
Ann Oncol
, vol.15
, pp. 493-497
-
-
Pectasides, D.1
Pectasides, M.2
Farmakis, D.3
Aravantinos, G.4
Nikolaou, M.5
Koumpou, M.6
Gaglia, A.7
Kostopoulou, V.8
Mylonakis, N.9
Skarlos, D.10
-
17
-
-
3142602935
-
Oxaliplatin and irinotecan plus granulocyte-colony stimulating factor as third-line treatment in relapsed or cisplatin-refractory germ-cell tumor patients: A phase II study
-
Pectasides D, Pectasides M, Farmakis D, Aravantinos G, Nikolaou M, Koumpou M, Gaglia A, Kostopoulou V, Mylonakis N, Economopoulos T and Raptis SA: Oxaliplatin and irinotecan plus granulocyte-colony stimulating factor as third-line treatment in relapsed or cisplatin-refractory germ-cell tumor patients: a phase II study. Eur Urol 46: 216-221, 2004.
-
(2004)
Eur Urol
, vol.46
, pp. 216-221
-
-
Pectasides, D.1
Pectasides, M.2
Farmakis, D.3
Aravantinos, G.4
Nikolaou, M.5
Koumpou, M.6
Gaglia, A.7
Kostopoulou, V.8
Mylonakis, N.9
Economopoulos, T.10
Raptis, S.A.11
-
18
-
-
33846531325
-
Molecular markers in extragonadal germ cell tumours: A matched case-control study
-
Pectasides D, Valavanis C, Nikolaou M, Aravantinos G, Lekka I, Skarlos D, Kalofonos Ch, Fountzilas G, Kostopoulou V, Zizi A, Economopoulos T and Arapantoni-Datioti P: Molecular markers in extragonadal germ cell tumours: a matched case-control study. Histopathology 50: 394-396, 2007.
-
(2007)
Histopathology
, vol.50
, pp. 394-396
-
-
Pectasides, D.1
Valavanis, C.2
Nikolaou, M.3
Aravantinos, G.4
Lekka, I.5
Skarlos, D.6
Kalofonos, C.7
Fountzilas, G.8
Kostopoulou, V.9
Zizi, A.10
Economopoulos, T.11
Arapantoni-Datioti, P.12
-
19
-
-
0037048311
-
DNA topoisomerase I and II expression in drug-resistant germ cell tumours
-
Berney DM, Shamash J, Gaffney J, Jordan S and Oliver RT: DNA topoisomerase I and II expression in drug-resistant germ cell tumours. Br J Cancer 87: 624-629, 2002.
-
(2002)
Br J Cancer
, vol.87
, pp. 624-629
-
-
Berney, D.M.1
Shamash, J.2
Gaffney, J.3
Jordan, S.4
Oliver, R.T.5
-
20
-
-
0025817249
-
Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors
-
Strohmeyer T, Peter S, Hartmann M, Munemitsu S, Ackermann R, Ullrich A and Slamon DJ: Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors. Cancer Res 51: 1811-1816, 1991.
-
(1991)
Cancer Res
, vol.51
, pp. 1811-1816
-
-
Strohmeyer, T.1
Peter, S.2
Hartmann, M.3
Munemitsu, S.4
Ackermann, R.5
Ullrich, A.6
Slamon, D.J.7
-
22
-
-
24944431729
-
Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults
-
McIntyre A, Summersgill B, Grygalewicz B, Gillis AJ, Stoop J, van Gurp RJ, Dennis N, Fisher C, Huddart R, Cooper C, Clark J, Oosterhuis JW, Looijenga LH and Shipley J: Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults. Cancer Res 65: 8085-8089, 2005.
-
(2005)
Cancer Res
, vol.65
, pp. 8085-8089
-
-
McIntyre, A.1
Summersgill, B.2
Grygalewicz, B.3
Gillis, A.J.4
Stoop, J.5
van Gurp, R.J.6
Dennis, N.7
Fisher, C.8
Huddart, R.9
Cooper, C.10
Clark, J.11
Oosterhuis, J.W.12
Looijenga, L.H.13
Shipley, J.14
-
23
-
-
0029929672
-
Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio
-
Chresta CM, Masters JR and Hickman JA: Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio. Cancer Res 56: 1834-1841, 1996.
-
(1996)
Cancer Res
, vol.56
, pp. 1834-1841
-
-
Chresta, C.M.1
Masters, J.R.2
Hickman, J.A.3
-
24
-
-
34548567398
-
Bax mutation and overexpression inversely correlate with immature phenotype and prognosis of childhood germ cell tumors
-
Addeo R, Crisci S, D'Angelo V, Vincenzi B, Casale F, Pettinato G, Donofrio V, Boldrini R, Alaggio R, Collini P, Bertorelle R, Di Tullio MT, Caraglia M, Terenziani M, Lo Curto M and Indolfi P: Bax mutation and overexpression inversely correlate with immature phenotype and prognosis of childhood germ cell tumors. Oncol Rep 77: 1155-1161, 2007.
-
(2007)
Oncol Rep
, vol.77
, pp. 1155-1161
-
-
Addeo, R.1
Crisci, S.2
D'Angelo, V.3
Vincenzi, B.4
Casale, F.5
Pettinato, G.6
Donofrio, V.7
Boldrini, R.8
Alaggio, R.9
Collini, P.10
Bertorelle, R.11
Di Tullio, M.T.12
Caraglia, M.13
Terenziani, M.14
Lo Curto, M.15
Indolfi, P.16
-
25
-
-
0042130382
-
Cluster analysis of p53 and Ki-67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor
-
Mazumdar M, Bacik J, Tickoo SK, Dobrzynski D, Donadio A, Bajorin D, Motzer R, Reuter V and Bosl GJ: Cluster analysis of p53 and Ki-67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor. J Clin Oncol 21: 2679-2688, 2003.
-
(2003)
J Clin Oncol
, vol.21
, pp. 2679-2688
-
-
Mazumdar, M.1
Bacik, J.2
Tickoo, S.K.3
Dobrzynski, D.4
Donadio, A.5
Bajorin, D.6
Motzer, R.7
Reuter, V.8
Bosl, G.J.9
-
26
-
-
0035942493
-
A p53 dose-response relationship for sensitivity to DNA damage in isogenic teratocarcinoma cells
-
Lutzker SG, Mathew R and Taller DR: A p53 dose-response relationship for sensitivity to DNA damage in isogenic teratocarcinoma cells. Oncogene 20: 2982-2986, 2001.
-
(2001)
Oncogene
, vol.20
, pp. 2982-2986
-
-
Lutzker, S.G.1
Mathew, R.2
Taller, D.R.3
-
27
-
-
0032493125
-
Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation
-
Houldsworth J, Xiao H, Murty VV, Chen W, Ray B, Reuter VE, Bosl GJ and Chaganti RS: Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation. Oncogene 16: 2345-2349, 1998.
-
(1998)
Oncogene
, vol.16
, pp. 2345-2349
-
-
Houldsworth, J.1
Xiao, H.2
Murty, V.V.3
Chen, W.4
Ray, B.5
Reuter, V.E.6
Bosl, G.J.7
Chaganti, R.S.8
-
28
-
-
0032963715
-
Distinct p53-independent apoptotic cell death signalling pathways in testicular germ cell tumour cell lines
-
Burger H, Nooter K, Boersma AW, van Wingerden KE, Looijenga LH, Jochemsen AG and Stoter G: Distinct p53-independent apoptotic cell death signalling pathways in testicular germ cell tumour cell lines. Int J Cancer 81: 620-628, 1999.
-
(1999)
Int J Cancer
, vol.81
, pp. 620-628
-
-
Burger, H.1
Nooter, K.2
Boersma, A.W.3
van Wingerden, K.E.4
Looijenga, L.H.5
Jochemsen, A.G.6
Stoter, G.7
-
29
-
-
26944495365
-
A p53-dominant transcriptional response to cisplatin in testicular germ cell tumor-derived human embryonal carcinoma
-
Kerley-Hamilton JS, Pike AM, Li N, DiRenzo J and Spinella MJ: A p53-dominant transcriptional response to cisplatin in testicular germ cell tumor-derived human embryonal carcinoma. Oncogene 24: 6090-6100, 2005.
-
(2005)
Oncogene
, vol.24
, pp. 6090-6100
-
-
Kerley-Hamilton, J.S.1
Pike, A.M.2
Li, N.3
DiRenzo, J.4
Spinella, M.J.5
-
30
-
-
34748915836
-
Molecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profiles
-
Duale N, Lindeman B, Komada M, Olsen AK, Andreassen A, Soderlund EJ and Brunborg G: Molecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profiles. Mol Cancer 6: 53, 2007.
-
(2007)
Mol Cancer
, vol.6
, pp. 53
-
-
Duale, N.1
Lindeman, B.2
Komada, M.3
Olsen, A.K.4
Andreassen, A.5
Soderlund, E.J.6
Brunborg, G.7
-
31
-
-
10144247897
-
Germ cell tumors of the testis overexpress wild-type p53
-
Guillou L, Estreicher A, Chaubert P, Hurlimann J, Kurt AM, Metthez G, Iggo R, Gray AC, Jichlinski P, Leisinger HJ and Benhattar J: Germ cell tumors of the testis overexpress wild-type p53. Am J Pathol 149: 1221-1228, 1996.
-
(1996)
Am J Pathol
, vol.149
, pp. 1221-1228
-
-
Guillou, L.1
Estreicher, A.2
Chaubert, P.3
Hurlimann, J.4
Kurt, A.M.5
Metthez, G.6
Iggo, R.7
Gray, A.C.8
Jichlinski, P.9
Leisinger, H.J.10
Benhattar, J.11
-
32
-
-
0037087768
-
Role of P53 and MDM2 in treatment response of human germ cell tumors
-
Kersemaekers AM, Mayer F, Molier M, van Weeren PC, Oosterhuis JW, Bokemeyer C and Looijenga LH: Role of P53 and MDM2 in treatment response of human germ cell tumors. J Clin Oncol 20: 1551-1561, 2002.
-
(2002)
J Clin Oncol
, vol.20
, pp. 1551-1561
-
-
Kersemaekers, A.M.1
Mayer, F.2
Molier, M.3
van Weeren, P.C.4
Oosterhuis, J.W.5
Bokemeyer, C.6
Looijenga, L.H.7
-
33
-
-
0032771490
-
Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer
-
Dingemans AM, Witlox MA, Stallaert RA, van der Valk P, Postmus PE and Giaccone G: Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer. Clin Cancer Res 5: 2048-2058, 1999.
-
(1999)
Clin Cancer Res
, vol.5
, pp. 2048-2058
-
-
Dingemans, A.M.1
Witlox, M.A.2
Stallaert, R.A.3
van der Valk, P.4
Postmus, P.E.5
Giaccone, G.6
-
34
-
-
9044231367
-
Prognostic significance of abnormal p53 accumulation in primary, resected non-small cell lung cancers
-
Nishio M, Koshikawa T, Kuroishi T, Suyama M, Uchida K, Tagaki Y, Washimi O, Sugiura T, Ariyoshi Y, Takahashi T, Ueda R and Takahashi T: Prognostic significance of abnormal p53 accumulation in primary, resected non-small cell lung cancers. J Clin Oncol 14: 497-502, 1996.
-
(1996)
J Clin Oncol
, vol.14
, pp. 497-502
-
-
Nishio, M.1
Koshikawa, T.2
Kuroishi, T.3
Suyama, M.4
Uchida, K.5
Tagaki, Y.6
Washimi, O.7
Sugiura, T.8
Ariyoshi, Y.9
Takahashi, T.10
Ueda, R.11
Takahashi, T.12
|